Department of Epidemiology, Mailman School of Public Health, Columbia University, 722W. 168th St. New York, NY 10032, USA.
Cornell University Law School, 306 Myron Taylor Hall Ithaca, NY 14853-4901, USA.
Int J Drug Policy. 2024 Apr;126:104380. doi: 10.1016/j.drugpo.2024.104380. Epub 2024 Mar 14.
Punitive legal responses to prenatal drug use may be associated with unintended adverse health consequences. However, in a rapidly shifting policy climate, current information has not been summarized. We conducted a survey of U.S. state policies that utilize criminal or civil legal system penalties to address prenatal drug use. We then systematically identified empirical studies evaluating these policies and summarized their potential public health impacts.
Using existing databases and original statutory research, we surveyed current U.S. state-level prenatal drug use policies authorizing explicit criminalization, involuntary commitment, civil child abuse substantiation, and parental rights termination. Next, we systematically identified quantitative associations between these policies and health outcomes, restricting to U.S.-based peer-reviewed research, published January 2000-December 2022. Results described study characteristics and synthesized the evidence on health-related harms and benefits associated with punitive policies. Validity threats were described narratively.
By 2022, two states had adopted policies explicitly authorizing criminal prosecution, and five states allowed pregnancy-specific and drug use-related involuntary civil commitment. Prenatal drug use was grounds for substantiating civil child abuse and terminating parental rights in 22 and five states, respectively. Of the 16 review-identified articles, most evaluated associations between punitive policies generally (k = 12), or civil child abuse policies specifically (k = 2), and multiple outcomes, including drug treatment utilization (k = 6), maltreatment reporting and foster care entry (k = 5), neonatal drug withdrawal syndrome (NDWS, k = 4) and other pregnancy and birth-related outcomes (k = 3). Most included studies reported null associations or suggested increases in adverse outcome following punitive policy adoption.
Nearly half of U.S. states have adopted policies that respond to prenatal drug use with legal system penalties. While additional research is needed to clarify whether such approaches engender overt health harms, current evidence indicates that punitive policies are not associated with public health benefits, and therefore constitute ineffective policy.
对产前药物使用采取惩罚性法律措施可能会带来意料之外的健康后果。然而,在政策环境迅速变化的情况下,目前还没有对相关信息进行总结。我们对美国利用刑事或民事法律制度来处理产前药物使用问题的州政策进行了调查。然后,我们系统地确定了评估这些政策的实证研究,并总结了它们可能对公共卫生产生的影响。
我们使用现有的数据库和原始法规研究,调查了美国目前授权明确刑事定罪、非自愿拘留、民事儿童虐待确认和父母权利终止的州级产前药物使用政策。接下来,我们系统地确定了这些政策与健康结果之间的定量关联,限制在美国进行的同行评议研究,发表时间为 2000 年 1 月至 2022 年 12 月。研究结果描述了研究特征,并综合了与惩罚性政策相关的健康相关危害和益处的证据。叙述性描述了有效性威胁。
到 2022 年,有两个州通过了明确授权刑事起诉的政策,有五个州允许与怀孕和药物使用相关的特定非自愿民事拘留。产前药物使用是确认民事儿童虐待和终止父母权利的依据,分别在 22 个和 5 个州。在 16 篇经审查确定的文章中,大多数评估了一般惩罚性政策(k = 12)或具体的儿童虐待政策(k = 2)与多种结果之间的关联,包括药物治疗利用(k = 6)、虐待报告和寄养进入(k = 5)、新生儿药物戒断综合征(NDWS,k = 4)和其他怀孕和分娩相关结果(k = 3)。大多数纳入的研究报告称,在采取惩罚性政策后,关联结果为无关联或表明不良后果增加。
近一半的美国州已经通过了利用法律制度来处理产前药物使用问题的政策。虽然需要进一步的研究来澄清这些方法是否会带来明显的健康危害,但目前的证据表明,惩罚性政策与公共卫生效益无关,因此是无效的政策。